See more : Lakeshore Acquisition II Corp. (LBBBR) Income Statement Analysis – Financial Results
Complete financial analysis of JTEC Corporation (3446.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JTEC Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Shankara Building Products Limited (SHANKARA.NS) Income Statement Analysis – Financial Results
- Lewis Group Limited (LEW.JO) Income Statement Analysis – Financial Results
- XD Inc. (XDNCF) Income Statement Analysis – Financial Results
- Boral Limited (BLD.AX) Income Statement Analysis – Financial Results
- Brookfield Infrastructure Corporation (BIPC.TO) Income Statement Analysis – Financial Results
JTEC Corporation (3446.T)
About JTEC Corporation
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan. Its X-ray mirrors are used for study in the pharmaceutical, electronic, material, food, beauty, and other fields. The company also designs, develops, manufactures, and sells automated cell culture systems, as well as automated systems in various fields. JTEC Corporation was founded in 1993 and is headquartered in Ibaraki, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.01B | 1.91B | 1.15B | 820.35M | 1.03B | 1.29B | 1.01B | 801.81M | 596.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 757.59M | 743.51M | 451.07M | 489.65M | 390.32M | 344.43M | 257.98M | 168.18M | 167.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.25B | 1.16B | 699.91M | 330.70M | 637.16M | 941.13M | 751.91M | 633.63M | 428.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 62.32% | 61.04% | 60.81% | 40.31% | 62.01% | 73.21% | 74.46% | 79.02% | 71.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 290.00M | 263.01M | 263.40M | 233.84M | 207.96M | 183.43M | 173.90M | 161.73M | 133.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 110.00M | 100.00M | 109.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 566.00M | 495.19M | 398.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 676.68M | 595.19M | 507.73M | 370.31M | 394.61M | 311.70M | 327.15M | 306.20M | 225.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 242.00K | 64.48M | 771.13M | 0.00 | 631.18M | 504.62M | 51.17M | 46.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 966.92M | 858.20M | 771.13M | 604.15M | 631.18M | 504.62M | 508.29M | 467.94M | 358.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 1.72B | 1.60B | 1.22B | 1.09B | 1.02B | 849.05M | 766.27M | 636.12M | 526.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Income | 6.00K | 6.00K | 5.00K | 9.00K | 2.70M | 67.00K | 21.00K | 46.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 3.28M | 3.92M | 3.90M | 378.00K | 442.00K | 439.00K | 621.00K | 1.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 149.15M | 145.15M | 131.59M | 94.34M | 93.09M | 61.59M | 56.81M | 70.71M | 54.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 437.18M | 510.65M | 107.47M | -179.11M | 118.29M | 557.62M | 310.00M | 261.73M | 124.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 21.75% | 27.09% | 9.43% | -21.83% | 12.43% | 43.44% | 33.37% | 33.82% | 20.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 285.84M | 306.67M | -23.08M | -273.45M | 34.63M | 436.51M | 243.62M | 165.69M | 70.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 14.22% | 16.07% | -2.01% | -33.33% | 3.37% | 33.95% | 24.12% | 20.66% | 11.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.10M | 54.90M | 43.20M | 34.39M | -9.87M | 59.09M | 8.95M | 24.24M | 44.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 284.74M | 361.57M | -28.02M | -239.06M | 24.76M | 495.59M | 252.57M | 189.93M | 114.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 14.16% | 18.95% | -2.43% | -29.14% | 2.41% | 38.55% | 25.01% | 23.69% | 19.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 85.15M | 123.38M | 4.10M | -68.35M | 8.41M | 163.42M | 78.06M | 60.00M | 30.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 199.59M | 238.19M | -32.13M | -170.71M | 16.36M | 332.17M | 174.52M | 129.93M | 83.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 9.93% | 12.48% | -2.79% | -20.81% | 1.59% | 25.84% | 17.28% | 16.20% | 14.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 33.96 | 40.58 | -5.48 | -29.16 | 2.80 | 57.11 | 32.76 | 25.38 | 9.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 33.96 | 40.58 | -5.48 | -29.16 | 2.79 | 56.39 | 32.17 | 25.38 | 9.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 5.88M | 5.87M | 5.86M | 5.85M | 5.85M | 5.82M | 5.33M | 5.12M | 8.55M | 8.47M | 8.35M | 8.35M | 8.35M | 8.20M | 3.79M | 7.57M | 7.57M |
| Weighted Avg Shares Out (Dil) | 5.88M | 5.87M | 5.86M | 5.85M | 5.87M | 5.89M | 5.42M | 5.12M | 8.70M | 8.68M | 8.66M | 8.50M | 8.36M | 8.20M | 3.79M | 7.57M | 7.57M |
Source: https://incomestatements.info
Category: Stock Reports